Endo, Inc., a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies, announced that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of Doxy 100.
We're pleased to provide choices to healthcare providers and hospital pharmacies as they work to deliver quality patient care, said Scott Sims, senior vice president and general manager, injectable solutions & generics at Endo. The doxycycline for injection strengthens our sterile injectable product portfolio and underscores our reputation as a reliable supplier of aseptic medicines.
According to IQVIA, doxycycline for injection 100 mg vial sales were approximately $49 million for the 12 months ended September 30, 2024.
Doxy 100 is a trademark of Fresenius Kabi.
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. The company passionate team members collaborate to develop and deliver these essential medicines
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!